Impacting the Future
 

iStock-469758618.jpg

 

At Juvena Therapeutics, we're not anti-aging.

We're pro-aging.

Why? Because this untapped, underserved market represents an opportunity for major breakthroughs in scientific research, investment ventures, and the quality of how we live. 

 

 

FAST FACTS ON THE
AGING MARKET

  • In 2010, the 65 and older population in the US was 40.2 million. By 2050, that number is expected to more than double to 88.5 million [...]

  • The United States spends more than $26 billion annually on additional health care costs for people over 65 who lose their ability to live independently over the course of a single year [...]

  • In 2000, 1.5 million people were institutionalized, and 33% of these people were admitted to long‐term health care facilities because of their inability to perform activities of daily living [...]

  • Increases in prevalence and treatment intensity of chronic disease are responsible for about 2/3 of the increase in health care costs over the past 20 years [...]

  • An older adults suffers a fall that requires an emergency room visit every 15 seconds. Every 29 minutes, an older American dies as a result of a fall [...]

 
O70IZ80.jpg
 

BIOLOGICS ARE THE BEST
THERAPEUTIC APPROACH

Aging is a treatable illness awaiting therapeutic solutions to reverse or prevent the cellular and organ-level accumulation of damage. At Juvena, we believe that biologics are the absolute best therapeutic approach. And the market is also tracking huge trends in support of the movement:

infographics aging market.jpg

*Source: Genetic Engineering and Biotechnology News:
“The Top 25 Best-Selling Drugs of 2014”


 

The vibrant future of the aging market is in our hands.
To learn more about making a positive impact with us, email:

INFO@JUVENATHERAPEUTICS.COM

09232-cover1-StructureCXD1_HYFAVORITE.png